• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载多柔比星的强稳定性聚乙二醇化透明质酸纳米粒:体内的矿化作用及其对肿瘤靶向性的影响。

Robust PEGylated hyaluronic acid nanoparticles as the carrier of doxorubicin: mineralization and its effect on tumor targetability in vivo.

机构信息

Department of Polymer Science and Engineering, College of Engineering, Sungkyunkwan University, Suwon 440-746, Republic of Korea.

出版信息

J Control Release. 2013 Jun 10;168(2):105-14. doi: 10.1016/j.jconrel.2013.02.022. Epub 2013 Mar 6.

DOI:10.1016/j.jconrel.2013.02.022
PMID:23474029
Abstract

The in vivo stability and tumor targetability of self-assembled polymeric nanoparticles are crucial for effective drug delivery. In this study, to develop biostable nanoparticles with high tumor targetability, poly(ethylene glycol)-conjugated hyaluronic acid nanoparticles (PEG-HANPs) were mineralized through controlled deposition of inorganic calcium and phosphate ions on the nanoparticular shell via a sequential addition method. The resulting nanoparticles (M-PEG-HANPs) had a smaller size (153.7±4.5nm) than bare PEG-HANPs (265.1±9.5nm), implying that mineralization allows the formation of compact nanoparticles. Interestingly, when the mineralized nanoparticles were exposed to acidic buffer conditions (<pH6.5), their sizes increased rapidly due to dissolution of the inorganic minerals. Doxorubicin (DOX), chosen as the model anticancer drug, was effectively encapsulated into the bare and mineralized nanoparticles. For bare PEG-HANPs, DOX was released in a sustained manner and its release rate was not dependent on the pH of the solution. On the other hand, DOX release from M-PEG-HANPs was pH-dependent: i.e. DOX was slowly released from nanoparticles under physiological condition (pH7.4), whereas its release rates were much higher at mildly acidic environments (<pH6.5). From in vivo biodistribution study, it was found that M-PEG-HANPs could reach the tumor site more effectively than bare PEG-HANPs. The antitumor efficacy of DOX-loaded nanoparticles was evaluated after systemic administration into the tumor-bearing mice. Of the samples tested, the most effective antitumor efficacy was observed for DOX-loaded M-PEG-HANPs. Overall, these results suggest that M-PEG-HANPs could be a promising carrier for an anticancer drug.

摘要

自组装聚合物纳米粒子的体内稳定性和肿瘤靶向性对于有效的药物传递至关重要。在这项研究中,为了开发具有高肿瘤靶向性的生物稳定纳米粒子,通过在纳米粒子壳上通过顺序添加方法用无机钙和磷酸盐离子进行控制沉积,使聚乙二醇-接枝透明质酸纳米粒子(PEG-HANPs)矿化。所得纳米粒子(M-PEG-HANPs)的粒径(153.7±4.5nm)小于裸 PEG-HANPs(265.1±9.5nm),这意味着矿化允许形成更紧凑的纳米粒子。有趣的是,当矿化纳米粒子暴露于酸性缓冲条件(<pH6.5)时,由于无机矿物质的溶解,其粒径迅速增加。阿霉素(DOX)被选为模型抗癌药物,被有效地包封到裸和矿化纳米粒子中。对于裸 PEG-HANPs,DOX 以持续的方式释放,并且其释放速率与溶液的 pH 值无关。另一方面,M-PEG-HANPs 中的 DOX 释放依赖于 pH:即在生理条件(pH7.4)下,纳米粒子中 DOX 的释放速度较慢,而在轻度酸性环境(<pH6.5)下,其释放速度要高得多。从体内生物分布研究中发现,M-PEG-HANPs 比裸 PEG-HANPs 更能有效地到达肿瘤部位。在荷瘤小鼠中进行全身给药后,评估了载 DOX 纳米粒子的抗肿瘤功效。在所测试的样品中,观察到载 DOX 的 M-PEG-HANPs 的抗肿瘤功效最有效。总体而言,这些结果表明 M-PEG-HANPs 可以成为抗癌药物的有前途的载体。

相似文献

1
Robust PEGylated hyaluronic acid nanoparticles as the carrier of doxorubicin: mineralization and its effect on tumor targetability in vivo.载多柔比星的强稳定性聚乙二醇化透明质酸纳米粒:体内的矿化作用及其对肿瘤靶向性的影响。
J Control Release. 2013 Jun 10;168(2):105-14. doi: 10.1016/j.jconrel.2013.02.022. Epub 2013 Mar 6.
2
The tumor accumulation and therapeutic efficacy of doxorubicin carried in calcium phosphate-reinforced polymer nanoparticles.载多柔比星的磷酸钙增强型聚合物纳米粒子的肿瘤积累和治疗效果。
Biomaterials. 2012 Aug;33(23):5788-97. doi: 10.1016/j.biomaterials.2012.04.057. Epub 2012 May 15.
3
Stealth CD44-targeted hyaluronic acid supramolecular nanoassemblies for doxorubicin delivery: probing the effect of uncovalent pegylation degree on cellular uptake and blood long circulation. stealth CD44 靶向透明质酸超分子纳米组装体用于阿霉素递送:探究非共价 PEG 化程度对细胞摄取和血液长循环的影响。
J Control Release. 2015 Jan 10;197:29-40. doi: 10.1016/j.jconrel.2014.10.024. Epub 2014 Nov 4.
4
Polyethylene glycol-conjugated hyaluronic acid-ceramide self-assembled nanoparticles for targeted delivery of doxorubicin.聚乙二醇修饰的透明质酸神经酰胺自组装纳米粒用于阿霉素的靶向递送。
Biomaterials. 2012 Feb;33(4):1190-200. doi: 10.1016/j.biomaterials.2011.10.064. Epub 2011 Nov 9.
5
Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts.可还原交联透明质酸纳米粒用于主动靶向和智能递药系统对耐药 CD44+人乳腺癌肿瘤异种移植瘤的治疗。
J Control Release. 2015 May 10;205:144-54. doi: 10.1016/j.jconrel.2015.01.012. Epub 2015 Jan 14.
6
Photo-crosslinked hyaluronic acid nanoparticles with improved stability for in vivo tumor-targeted drug delivery.光交联透明质酸纳米粒提高体内肿瘤靶向药物递送的稳定性。
Biomaterials. 2013 Jul;34(21):5273-80. doi: 10.1016/j.biomaterials.2013.03.050. Epub 2013 Apr 13.
7
Hyaluronic acid ion-pairing nanoparticles for targeted tumor therapy.用于靶向肿瘤治疗的透明质酸离子对纳米颗粒。
J Control Release. 2016 Mar 10;225:170-82. doi: 10.1016/j.jconrel.2016.01.049. Epub 2016 Jan 27.
8
Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.透明质酸锚定的阿霉素聚乳酸-羟基乙酸共聚物纳米颗粒载体的研制与表征
Nanomedicine. 2007 Dec;3(4):246-57. doi: 10.1016/j.nano.2007.09.004.
9
Smart nanocarrier based on PEGylated hyaluronic acid for cancer therapy.基于聚乙二醇化透明质酸的智能纳米载体用于癌症治疗。
ACS Nano. 2011 Nov 22;5(11):8591-9. doi: 10.1021/nn202070n. Epub 2011 Oct 11.
10
Bioreducible core-crosslinked hyaluronic acid micelle for targeted cancer therapy.生物可还原核心交联透明质酸胶束用于靶向癌症治疗。
J Control Release. 2015 Feb 28;200:158-66. doi: 10.1016/j.jconrel.2014.12.032. Epub 2014 Dec 27.

引用本文的文献

1
Self-immolative nanosensitizer for glutathione depletion- assisted sonodynamic therapy.用于谷胱甘肽耗竭辅助声动力学治疗的自毁纳米敏化剂。
Theranostics. 2022 Oct 24;12(17):7465-7475. doi: 10.7150/thno.75007. eCollection 2022.
2
Hyaluronic acid-based nano drug delivery systems for breast cancer treatment: Recent advances.用于乳腺癌治疗的基于透明质酸的纳米药物递送系统:最新进展
Front Bioeng Biotechnol. 2022 Aug 24;10:990145. doi: 10.3389/fbioe.2022.990145. eCollection 2022.
3
Emerging nanoformulation strategies for phytocompounds and applications from drug delivery to phototherapy to imaging.
用于植物化合物的新兴纳米制剂策略及其从药物递送、光疗到成像的应用。
Bioact Mater. 2021 Dec 20;14:182-205. doi: 10.1016/j.bioactmat.2021.11.027. eCollection 2022 Aug.
4
Bioorthogonally surface-edited extracellular vesicles based on metabolic glycoengineering for CD44-mediated targeting of inflammatory diseases.基于代谢糖基工程的生物正交表面编辑细胞外囊泡用于 CD44 介导的炎症性疾病靶向治疗。
J Extracell Vesicles. 2021 Mar;10(5):e12077. doi: 10.1002/jev2.12077. Epub 2021 Mar 12.
5
Next-Generation Vaccines: Nanoparticle-Mediated DNA and mRNA Delivery.下一代疫苗:基于纳米颗粒的 DNA 和 mRNA 递送。
Adv Healthc Mater. 2021 Apr;10(8):e2001812. doi: 10.1002/adhm.202001812. Epub 2021 Jan 18.
6
Tumor Microenvironment-Stimuli Responsive Nanoparticles for Anticancer Therapy.用于抗癌治疗的肿瘤微环境刺激响应性纳米颗粒
Front Mol Biosci. 2020 Dec 18;7:610533. doi: 10.3389/fmolb.2020.610533. eCollection 2020.
7
Stimuli-Responsive Nanomaterials for Application in Antitumor Therapy and Drug Delivery.用于抗肿瘤治疗和药物递送的刺激响应性纳米材料
Pharmaceutics. 2020 Jul 4;12(7):630. doi: 10.3390/pharmaceutics12070630.
8
Liver-targeted delivery of TSG-6 by calcium phosphate nanoparticles for the management of liver fibrosis.通过磷酸钙纳米粒实现 TSG-6 的肝脏靶向递送,用于肝纤维化的治疗。
Theranostics. 2020 Jan 1;10(1):36-49. doi: 10.7150/thno.37301. eCollection 2020.
9
Design of Soft Nanocarriers Combining Hyaluronic Acid with Another Functional Polymer for Cancer Therapy and Other Biomedical Applications.用于癌症治疗及其他生物医学应用的、将透明质酸与另一种功能聚合物相结合的软纳米载体的设计
Pharmaceutics. 2019 Jul 15;11(7):338. doi: 10.3390/pharmaceutics11070338.
10
A Method to Encapsulate Small Organic Molecules in Calcium Phosphate Nanoparticles Based on the Supramolecular Chemistry of Cyclodextrin.一种基于环糊精超分子化学将小有机分子封装于磷酸钙纳米颗粒中的方法。
Micromachines (Basel). 2017 Sep 27;8(10):291. doi: 10.3390/mi8100291.